Cargando…

Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer

Recent studies have linked expression of lectin-like ox-LDL receptor 1 (OLR1) to tumorigenesis. We analyzed microarray data from Olr1 knockout (KO) and wild type (WT) mice for genes involved in cellular transformation and evaluated effects of OLR1 over-expression in normal mammary epithelial cells (...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaidakov, Magomed, Mitra, Sona, Kang, Bum-Yong, Wang, Xianwei, Kadlubar, Susan, Novelli, Giuseppe, Raj, Vinay, Winters, Maria, Carter, Weleetka C., Mehta, Jawahar L.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102697/
https://www.ncbi.nlm.nih.gov/pubmed/21637860
http://dx.doi.org/10.1371/journal.pone.0020277
_version_ 1782204412522921984
author Khaidakov, Magomed
Mitra, Sona
Kang, Bum-Yong
Wang, Xianwei
Kadlubar, Susan
Novelli, Giuseppe
Raj, Vinay
Winters, Maria
Carter, Weleetka C.
Mehta, Jawahar L.
author_facet Khaidakov, Magomed
Mitra, Sona
Kang, Bum-Yong
Wang, Xianwei
Kadlubar, Susan
Novelli, Giuseppe
Raj, Vinay
Winters, Maria
Carter, Weleetka C.
Mehta, Jawahar L.
author_sort Khaidakov, Magomed
collection PubMed
description Recent studies have linked expression of lectin-like ox-LDL receptor 1 (OLR1) to tumorigenesis. We analyzed microarray data from Olr1 knockout (KO) and wild type (WT) mice for genes involved in cellular transformation and evaluated effects of OLR1 over-expression in normal mammary epithelial cells (MCF10A) and breast cancer cells (HCC1143) in terms of gene expression, migration, adhesion and transendothelial migration. Twenty-six out of 238 genes were inhibited in tissues of OLR1 KO mice; the vast majority of OLR1 sensitive genes contained NF-κB binding sites in their promoters. Further studies revealed broad inhibition of NF-kB target genes outside of the transformation-associated gene pool, with enrichment themes of defense response, immune response, apoptosis, proliferation, and wound healing. Transcriptome of Olr1 KO mice also revealed inhibition of de novo lipogenesis, rate-limiting enzymes fatty acid synthase (Fasn), stearoyl-CoA desaturase (Scd1) and ELOVL family member 6 (Elovl6), as well as lipolytic phospholipase A2 group IVB (Pla2g4b). In studies comparing MCF10A and HCC1143, the latter displayed 60% higher OLR1 expression. Forced over-expression of OLR1 resulted in upregulation of NF-κB (p65) and its target pro-oncogenes involved in inhibition of apoptosis (BCL2, BCL2A1, TNFAIP3) and regulation of cell cycle (CCND2) in both cell lines. Basal expression of FASN, SCD1 and PLA2G4B, as well as lipogenesis transcription factors PPARA, SREBF2 and CREM, was higher in HCC1143 cells. Over-expression of OLR1 in HCC1143 cells also enhanced cell migration, without affecting their adherence to TNFα-activated endothelium or transendothelial migration. On the other hand, OLR1 neutralizing antibody inhibited both adhesion and transmigration of untreated HCC1143 cells. We conclude that OLR1 may act as an oncogene by activation of NF-kB target genes responsible for proliferation, migration and inhibition of apoptosis and de novo lipogenesis genes.
format Text
id pubmed-3102697
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31026972011-06-02 Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer Khaidakov, Magomed Mitra, Sona Kang, Bum-Yong Wang, Xianwei Kadlubar, Susan Novelli, Giuseppe Raj, Vinay Winters, Maria Carter, Weleetka C. Mehta, Jawahar L. PLoS One Research Article Recent studies have linked expression of lectin-like ox-LDL receptor 1 (OLR1) to tumorigenesis. We analyzed microarray data from Olr1 knockout (KO) and wild type (WT) mice for genes involved in cellular transformation and evaluated effects of OLR1 over-expression in normal mammary epithelial cells (MCF10A) and breast cancer cells (HCC1143) in terms of gene expression, migration, adhesion and transendothelial migration. Twenty-six out of 238 genes were inhibited in tissues of OLR1 KO mice; the vast majority of OLR1 sensitive genes contained NF-κB binding sites in their promoters. Further studies revealed broad inhibition of NF-kB target genes outside of the transformation-associated gene pool, with enrichment themes of defense response, immune response, apoptosis, proliferation, and wound healing. Transcriptome of Olr1 KO mice also revealed inhibition of de novo lipogenesis, rate-limiting enzymes fatty acid synthase (Fasn), stearoyl-CoA desaturase (Scd1) and ELOVL family member 6 (Elovl6), as well as lipolytic phospholipase A2 group IVB (Pla2g4b). In studies comparing MCF10A and HCC1143, the latter displayed 60% higher OLR1 expression. Forced over-expression of OLR1 resulted in upregulation of NF-κB (p65) and its target pro-oncogenes involved in inhibition of apoptosis (BCL2, BCL2A1, TNFAIP3) and regulation of cell cycle (CCND2) in both cell lines. Basal expression of FASN, SCD1 and PLA2G4B, as well as lipogenesis transcription factors PPARA, SREBF2 and CREM, was higher in HCC1143 cells. Over-expression of OLR1 in HCC1143 cells also enhanced cell migration, without affecting their adherence to TNFα-activated endothelium or transendothelial migration. On the other hand, OLR1 neutralizing antibody inhibited both adhesion and transmigration of untreated HCC1143 cells. We conclude that OLR1 may act as an oncogene by activation of NF-kB target genes responsible for proliferation, migration and inhibition of apoptosis and de novo lipogenesis genes. Public Library of Science 2011-05-26 /pmc/articles/PMC3102697/ /pubmed/21637860 http://dx.doi.org/10.1371/journal.pone.0020277 Text en Khaidakov et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Khaidakov, Magomed
Mitra, Sona
Kang, Bum-Yong
Wang, Xianwei
Kadlubar, Susan
Novelli, Giuseppe
Raj, Vinay
Winters, Maria
Carter, Weleetka C.
Mehta, Jawahar L.
Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer
title Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer
title_full Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer
title_fullStr Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer
title_full_unstemmed Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer
title_short Oxidized LDL Receptor 1 (OLR1) as a Possible Link between Obesity, Dyslipidemia and Cancer
title_sort oxidized ldl receptor 1 (olr1) as a possible link between obesity, dyslipidemia and cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102697/
https://www.ncbi.nlm.nih.gov/pubmed/21637860
http://dx.doi.org/10.1371/journal.pone.0020277
work_keys_str_mv AT khaidakovmagomed oxidizedldlreceptor1olr1asapossiblelinkbetweenobesitydyslipidemiaandcancer
AT mitrasona oxidizedldlreceptor1olr1asapossiblelinkbetweenobesitydyslipidemiaandcancer
AT kangbumyong oxidizedldlreceptor1olr1asapossiblelinkbetweenobesitydyslipidemiaandcancer
AT wangxianwei oxidizedldlreceptor1olr1asapossiblelinkbetweenobesitydyslipidemiaandcancer
AT kadlubarsusan oxidizedldlreceptor1olr1asapossiblelinkbetweenobesitydyslipidemiaandcancer
AT novelligiuseppe oxidizedldlreceptor1olr1asapossiblelinkbetweenobesitydyslipidemiaandcancer
AT rajvinay oxidizedldlreceptor1olr1asapossiblelinkbetweenobesitydyslipidemiaandcancer
AT wintersmaria oxidizedldlreceptor1olr1asapossiblelinkbetweenobesitydyslipidemiaandcancer
AT carterweleetkac oxidizedldlreceptor1olr1asapossiblelinkbetweenobesitydyslipidemiaandcancer
AT mehtajawaharl oxidizedldlreceptor1olr1asapossiblelinkbetweenobesitydyslipidemiaandcancer